Carcinoembryonic+Antigen+CEA

By Targets:	ADC Antibody (1) Interleukin Related (1) Radionuclide-Drug Conjugates (RDCs) (1) Transmembrane Glycoprotein (5)
By Research Areas:	Cancer (8) Inflammation/Immunology (1)

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99160

Labetuzumab hMN14	Transmembrane Glycoprotein	Cancer
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .

HY-P99498

Cergutuzumab amunaleukin CEA-IL2v; RG 7813; RO 6895882	Interleukin Related	Inflammation/Immunology Cancer
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .

HY-P991060

Cergutuzumab	Transmembrane Glycoprotein	Cancer
Cergutuzumab is a fully human IgG1 antibody that targets carcinoembryonic antigen (CEA, CEACAM5, CD66e). Cergutuzumab can be used to form the recombinant protein Cergutuzumab amunaleukin (HY-P99498) .

HY-P991068

hT84.66-M5A	Transmembrane Glycoprotein	Cancer
hT84.66-M5A is a humanized IgG1 antibody that targets *carcinoembryonic antigen (CEA)*. The isotype control for hT84.66-M5A can refer to Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P9937

Arcitumomab IMMU-4	Transmembrane Glycoprotein	Cancer
Arcitumomab is a murine anti-carcinoembryonic antigen (CEA) monoclonal antibody Fab’ fragment. Arcitumomab can be labeled with technetium-99m and can be used for single-photon emission computed tomography (SPECT) imaging .

HY-P992339

cT84.66	Radionuclide-Drug Conjugates (RDCs)	Cancer
cT84.66 is a highly efficient tumor-targeting agent against *carcinoembryonic antigen (CEA). cT84.66 engages in bivalent binding with CEA via variable region antigen*-binding sites, enabling precise targeting of CEA-producing tumor cells for delivery of therapeutic radiation. cT84.66 exhibits high tumor uptake rate, rapid clearance rate, and excellent tumor-to-blood ratio. With dual functions as an imaging agent and an antibody-directed radiotherapy agent, cT84.66 is widely used in studies of colorectal cancer and metastatic CEA-positive malignancies .

HY-P992459

SGM-101 Antibody	ADC Antibody Transmembrane Glycoprotein	Cancer
SGM-101 Antibody is a chimeric monoclonal antibody targeting *carcinoembryonic antigen (CEA). SGM-101 Antibody can serve as a tumor-specific fluorescent imaging probe after being covalently conjugated with the near-infrared fluorescent dye BM104 . SGM-101 Antibody accumulates in CEA-positive tumor tissues via antigen*-antibody specific binding, and emits near-infrared fluorescence to enable imaging of tumor lesions. SGM-101 Antibody can be used in research related to gastric cancer, colorectal cancer, pancreatic cancer, non-small cell lung cancer, breast cancer, peritoneal carcinomatosis, and liver metastases .

Cat. No.	Product Name	Target	Research Area

HY-P0277

Carcinoembryonic antigen peptide 1 CEA peptide	Peptides	Cancer
Carcinoembryonic antigen peptide 1 (CEA peptide) is a carcinoembryonic antigen (CEA)-derived peptide. Carcinoembryonic antigen peptide 1 is a potential HLA-A*0201-restricted CTL epitope that can be used for the study of CTL-mediated epithelial-derived cancers .

Cat. No.	Product Name	Target	Research Area	Image

HY-P99160

Labetuzumab hMN14	Transmembrane Glycoprotein	Cancer
Labetuzumab is a humanised anti-carcinoembryonic antigen (CEA) monoclonal antibody that inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy .

HY-P99498

Cergutuzumab amunaleukin CEA-IL2v; RG 7813; RO 6895882	Interleukin Related	Inflammation/Immunology Cancer
Cergutuzumab amunaleukin (CEA-IL2v) is a monomeric carcinoembryonic antigen (CEA)-targeted IL-2 variant-based immunocytokine. Cergutuzumab amunaleukin has immunostimulating and antineoplastic activities .

HY-P991060

Cergutuzumab	Transmembrane Glycoprotein	Cancer
Cergutuzumab is a fully human IgG1 antibody that targets carcinoembryonic antigen (CEA, CEACAM5, CD66e). Cergutuzumab can be used to form the recombinant protein Cergutuzumab amunaleukin (HY-P99498) .

HY-P991068

hT84.66-M5A	Transmembrane Glycoprotein	Cancer
hT84.66-M5A is a humanized IgG1 antibody that targets *carcinoembryonic antigen (CEA)*. The isotype control for hT84.66-M5A can refer to Human IgG1 kappa, Isotype Control (HY-P99001) .

HY-P9937

Arcitumomab IMMU-4	Transmembrane Glycoprotein	Cancer
Arcitumomab is a murine anti-carcinoembryonic antigen (CEA) monoclonal antibody Fab’ fragment. Arcitumomab can be labeled with technetium-99m and can be used for single-photon emission computed tomography (SPECT) imaging .

HY-P992339

cT84.66	Radionuclide-Drug Conjugates (RDCs)	Cancer
cT84.66 is a highly efficient tumor-targeting agent against *carcinoembryonic antigen (CEA). cT84.66 engages in bivalent binding with CEA via variable region antigen*-binding sites, enabling precise targeting of CEA-producing tumor cells for delivery of therapeutic radiation. cT84.66 exhibits high tumor uptake rate, rapid clearance rate, and excellent tumor-to-blood ratio. With dual functions as an imaging agent and an antibody-directed radiotherapy agent, cT84.66 is widely used in studies of colorectal cancer and metastatic CEA-positive malignancies .

HY-P992459

SGM-101 Antibody	ADC Antibody Transmembrane Glycoprotein	Cancer
SGM-101 Antibody is a chimeric monoclonal antibody targeting *carcinoembryonic antigen (CEA). SGM-101 Antibody can serve as a tumor-specific fluorescent imaging probe after being covalently conjugated with the near-infrared fluorescent dye BM104 . SGM-101 Antibody accumulates in CEA-positive tumor tissues via antigen*-antibody specific binding, and emits near-infrared fluorescence to enable imaging of tumor lesions. SGM-101 Antibody can be used in research related to gastric cancer, colorectal cancer, pancreatic cancer, non-small cell lung cancer, breast cancer, peritoneal carcinomatosis, and liver metastases .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-P0277

Carcinoembryonic antigen peptide 1 CEA peptide	Natural Products Classification of Application Fields Endogenous metabolite Disease Research Fields Source Classification Cancer	Others
Carcinoembryonic antigen peptide 1 (CEA peptide) is a carcinoembryonic antigen (CEA)-derived peptide. Carcinoembryonic antigen peptide 1 is a potential HLA-A*0201-restricted CTL epitope that can be used for the study of CTL-mediated epithelial-derived cancers .

Species:	Human (10) Cynomolgus (2)
Tag:	His (10) Avi (5) Fc (2)
Source:	HEK293 (12)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P76817

	CEACAM5 Protein, Cynomolgus (HEK293, His) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Cynomolgus	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Cynomolgus (HEK293, His) is the recombinant cynomolgus-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P75356

	CEACAM5 Protein, Human (HEK293, His, solution) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, His, solution) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-His labeled tag.

HY-P72362

	CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-Avi, C-6*His labeled tag.

HY-P75355

	CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (Biotinylated, HEK293, C-His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with N-His, N-GST labeled tag.

HY-P705004

	CEACAM5 Protein, Human (Biotinylated, HEK293, Fc-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293

HY-P705137

	CEACAM5 Protein, Cynomolgus (Biotinylated, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Cynomolgus	HEK293

HY-P705005

	CEACAM5 Protein, Human (Biotinylated, 187a.a, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293

HY-P705006

	CEACAM5 Protein, Human (Biotinylated, 83a.a, HEK293, His-Avi) Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e	Human	HEK293

HY-P70675

	CEACAM5 Protein, Human (HEK293, His) 1 Publications Verification Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (HEK293, His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293 , with C-6*His labeled tag.

HY-P704499

	CEACAM5 Protein, Human (187a.a, HEK293, His) Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (187a.a, HEK293, His) is the recombinant human-derived CEACAM5 protein, expressed by HEK293, with C-His labeled tag.

HY-P704497

	FITC-Labeled CEACAM5 Protein, Human (HEK293, C-His) Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. FITC-Labeled CEACAM5 Protein, Human (HEK293, C-His) is the recombinant human-derived FITC-Labeled CEACAM5 protein, expressed by HEK293, with C-His labeled tag.

HY-P704498

	CEACAM5 Protein, Human (137a.a, HEK293, Llama Fc) Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e; CEACAM5	Human	HEK293
	CEACAM5 protein is a cell surface glycoprotein that cooperates with carcinoembryonic antigen-related molecules (such as CEACAM6) to participate in cell adhesion, intracellular signaling, and tumor progression. CEACAM5 Protein, Human (137a.a, HEK293, Llama Fc) is the recombinant human-derived CEACAM5 protein, expressed by HEK293, with C-Llama Fc labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (2)
Reactivity:	Human (2)
Application:	IHC-P (2) IF-Tissue (2) IHC-F (2) WB (2)
Isotype:	IgG (1)
Conjugation:	Non-conjugated (2) Biotin (6)
Clonality:	Monoclonal (1)
Modification:	Unmodified (1)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P85091

	CEA Antibody (YA4783) CEACAM5; CEA; Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD antigen CD66e	WB, IHC-P, IHC-F, IF-Tissue	Human
	CEA Antibody (YA4783) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CEA.

HY-P85091A

	CEA Antibody (YA4783)(PBS only) CEACAM5; CEA; Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD antigen CD66e	WB, IHC-P, IHC-F, IF-Tissue	Human
	CEA Antibody (YA4783) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to CEA.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies

Carcinoembryonic+Antigen+CEA

Inhibitors & Agonists

Peptides

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Antibodies

Natural
Products